Report Detail

Pharma & Healthcare Global Fluralaner API Market Growth 2022-2028

  • RnM4488433
  • |
  • 30 August, 2022
  • |
  • Global
  • |
  • 94 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.

The global market for Fluralaner API is estimated to increase from US$ 66 million in 2021 to reach US$ 90 million by 2028, exhibiting a CAGR of 4.7% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.

Report Coverage
This latest report provides a deep insight into the global Fluralaner API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Fluralaner API market, with both quantitative and qualitative data, to help readers understand how the Fluralaner API market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.

Market Segmentation:
The study segments the Fluralaner API market and forecasts the market size by Type (Purity above 98% and Purity below 98%,), by Application (Oral Drug and Topical Drug.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Purity above 98%
Purity below 98%

Segmentation by application
Oral Drug
Topical Drug

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology

Chapter Introduction
Chapter 1: Scope of Fluralaner API, Research Methodology, etc.
Chapter 2: Executive Summary, global Fluralaner API market size (sales and revenue) and CAGR, Fluralaner API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Fluralaner API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Fluralaner API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Fluralaner API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, Zhejiang Gihi Chemicals, Hunan Huateng Pharmaceutical and Taizhou Crene Biotechnology, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Fluralaner API Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Fluralaner API by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Fluralaner API by Country/Region, 2017, 2022 & 2028
  • 2.2 Fluralaner API Segment by Type
    • 2.2.1 Purity above 98%
    • 2.2.2 Purity below 98%
  • 2.3 Fluralaner API Sales by Type
    • 2.3.1 Global Fluralaner API Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Fluralaner API Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Fluralaner API Sale Price by Type (2017-2022)
  • 2.4 Fluralaner API Segment by Application
    • 2.4.1 Oral Drug
    • 2.4.2 Topical Drug
  • 2.5 Fluralaner API Sales by Application
    • 2.5.1 Global Fluralaner API Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Fluralaner API Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Fluralaner API Sale Price by Application (2017-2022)

3 Global Fluralaner API by Company

  • 3.1 Global Fluralaner API Breakdown Data by Company
    • 3.1.1 Global Fluralaner API Annual Sales by Company (2020-2022)
    • 3.1.2 Global Fluralaner API Sales Market Share by Company (2020-2022)
  • 3.2 Global Fluralaner API Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Fluralaner API Revenue by Company (2020-2022)
    • 3.2.2 Global Fluralaner API Revenue Market Share by Company (2020-2022)
  • 3.3 Global Fluralaner API Sale Price by Company
  • 3.4 Key Manufacturers Fluralaner API Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Fluralaner API Product Location Distribution
    • 3.4.2 Players Fluralaner API Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Fluralaner API by Geographic Region

  • 4.1 World Historic Fluralaner API Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Fluralaner API Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Fluralaner API Annual Revenue by Geographic Region
  • 4.2 World Historic Fluralaner API Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Fluralaner API Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Fluralaner API Annual Revenue by Country/Region
  • 4.3 Americas Fluralaner API Sales Growth
  • 4.4 APAC Fluralaner API Sales Growth
  • 4.5 Europe Fluralaner API Sales Growth
  • 4.6 Middle East & Africa Fluralaner API Sales Growth

5 Americas

  • 5.1 Americas Fluralaner API Sales by Country
    • 5.1.1 Americas Fluralaner API Sales by Country (2017-2022)
    • 5.1.2 Americas Fluralaner API Revenue by Country (2017-2022)
  • 5.2 Americas Fluralaner API Sales by Type
  • 5.3 Americas Fluralaner API Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Fluralaner API Sales by Region
    • 6.1.1 APAC Fluralaner API Sales by Region (2017-2022)
    • 6.1.2 APAC Fluralaner API Revenue by Region (2017-2022)
  • 6.2 APAC Fluralaner API Sales by Type
  • 6.3 APAC Fluralaner API Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Fluralaner API by Country
    • 7.1.1 Europe Fluralaner API Sales by Country (2017-2022)
    • 7.1.2 Europe Fluralaner API Revenue by Country (2017-2022)
  • 7.2 Europe Fluralaner API Sales by Type
  • 7.3 Europe Fluralaner API Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Fluralaner API by Country
    • 8.1.1 Middle East & Africa Fluralaner API Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Fluralaner API Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Fluralaner API Sales by Type
  • 8.3 Middle East & Africa Fluralaner API Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Fluralaner API
  • 10.3 Manufacturing Process Analysis of Fluralaner API
  • 10.4 Industry Chain Structure of Fluralaner API

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Fluralaner API Distributors
  • 11.3 Fluralaner API Customer

12 World Forecast Review for Fluralaner API by Geographic Region

  • 12.1 Global Fluralaner API Market Size Forecast by Region
    • 12.1.1 Global Fluralaner API Forecast by Region (2023-2028)
    • 12.1.2 Global Fluralaner API Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Fluralaner API Forecast by Type
  • 12.7 Global Fluralaner API Forecast by Application

13 Key Players Analysis

  • 13.1 Nissan Chemical
    • 13.1.1 Nissan Chemical Company Information
    • 13.1.2 Nissan Chemical Fluralaner API Product Offered
    • 13.1.3 Nissan Chemical Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Nissan Chemical Main Business Overview
    • 13.1.5 Nissan Chemical Latest Developments
  • 13.2 Hikal
    • 13.2.1 Hikal Company Information
    • 13.2.2 Hikal Fluralaner API Product Offered
    • 13.2.3 Hikal Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Hikal Main Business Overview
    • 13.2.5 Hikal Latest Developments
  • 13.3 Hubei Masteam Bio-tech
    • 13.3.1 Hubei Masteam Bio-tech Company Information
    • 13.3.2 Hubei Masteam Bio-tech Fluralaner API Product Offered
    • 13.3.3 Hubei Masteam Bio-tech Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Hubei Masteam Bio-tech Main Business Overview
    • 13.3.5 Hubei Masteam Bio-tech Latest Developments
  • 13.4 Jiangsu Rivocean
    • 13.4.1 Jiangsu Rivocean Company Information
    • 13.4.2 Jiangsu Rivocean Fluralaner API Product Offered
    • 13.4.3 Jiangsu Rivocean Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Jiangsu Rivocean Main Business Overview
    • 13.4.5 Jiangsu Rivocean Latest Developments
  • 13.5 Shaanxi Dideu
    • 13.5.1 Shaanxi Dideu Company Information
    • 13.5.2 Shaanxi Dideu Fluralaner API Product Offered
    • 13.5.3 Shaanxi Dideu Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Shaanxi Dideu Main Business Overview
    • 13.5.5 Shaanxi Dideu Latest Developments
  • 13.6 Zhejiang Gihi Chemicals
    • 13.6.1 Zhejiang Gihi Chemicals Company Information
    • 13.6.2 Zhejiang Gihi Chemicals Fluralaner API Product Offered
    • 13.6.3 Zhejiang Gihi Chemicals Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Zhejiang Gihi Chemicals Main Business Overview
    • 13.6.5 Zhejiang Gihi Chemicals Latest Developments
  • 13.7 Hunan Huateng Pharmaceutical
    • 13.7.1 Hunan Huateng Pharmaceutical Company Information
    • 13.7.2 Hunan Huateng Pharmaceutical Fluralaner API Product Offered
    • 13.7.3 Hunan Huateng Pharmaceutical Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Hunan Huateng Pharmaceutical Main Business Overview
    • 13.7.5 Hunan Huateng Pharmaceutical Latest Developments
  • 13.8 Taizhou Crene Biotechnology
    • 13.8.1 Taizhou Crene Biotechnology Company Information
    • 13.8.2 Taizhou Crene Biotechnology Fluralaner API Product Offered
    • 13.8.3 Taizhou Crene Biotechnology Fluralaner API Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Taizhou Crene Biotechnology Main Business Overview
    • 13.8.5 Taizhou Crene Biotechnology Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Fluralaner API. Industry analysis & Market Report on Fluralaner API is a syndicated market report, published as Global Fluralaner API Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Fluralaner API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,246.42
6,492.84
3,733.20
7,466.40
529,236.00
1,058,472.00
298,326.60
596,653.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report